22 Feb 2016 --- The US Food and Drug Administration (FDA) has sent eight warning letters to manufacturers of cannabidiol (CBD) dietary supplement and food products, causing the debate over hemp CBD’s legal status to continue. The warning letters cite prohibited health claims used to market the products, as well as CBD’s invalid status as a dietary ingredient due to its presence in two drug applications currently under consideration.
